rs10997691
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_013266.4(CTNNA3):c.579+15T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.133 in 1,610,468 control chromosomes in the GnomAD database, including 17,187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1614 hom., cov: 32)
Exomes 𝑓: 0.13 ( 15573 hom. )
Consequence
CTNNA3
NM_013266.4 intron
NM_013266.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0890
Publications
8 publications found
Genes affected
CTNNA3 (HGNC:2511): (catenin alpha 3) This gene encodes a protein that belongs to the vinculin/alpha-catenin family. The encoded protein plays a role in cell-cell adhesion in muscle cells. Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia, familial 13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
CTNNA3 Gene-Disease associations (from GenCC):
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- arrhythmogenic right ventricular dysplasia 13Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital heart diseaseInheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 10-67521827-A-C is Benign according to our data. Variant chr10-67521827-A-C is described in ClinVar as Benign. ClinVar VariationId is 1248579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CTNNA3 | NM_013266.4 | c.579+15T>G | intron_variant | Intron 5 of 17 | ENST00000433211.7 | NP_037398.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTNNA3 | ENST00000433211.7 | c.579+15T>G | intron_variant | Intron 5 of 17 | 1 | NM_013266.4 | ENSP00000389714.1 |
Frequencies
GnomAD3 genomes AF: 0.131 AC: 19898AN: 152038Hom.: 1610 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
19898
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.165 AC: 41059AN: 249198 AF XY: 0.171 show subpopulations
GnomAD2 exomes
AF:
AC:
41059
AN:
249198
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.133 AC: 194289AN: 1458312Hom.: 15573 Cov.: 31 AF XY: 0.139 AC XY: 100555AN XY: 725472 show subpopulations
GnomAD4 exome
AF:
AC:
194289
AN:
1458312
Hom.:
Cov.:
31
AF XY:
AC XY:
100555
AN XY:
725472
show subpopulations
African (AFR)
AF:
AC:
2766
AN:
33302
American (AMR)
AF:
AC:
7438
AN:
44020
Ashkenazi Jewish (ASJ)
AF:
AC:
2583
AN:
25924
East Asian (EAS)
AF:
AC:
12184
AN:
39676
South Asian (SAS)
AF:
AC:
26329
AN:
85816
European-Finnish (FIN)
AF:
AC:
11933
AN:
53310
Middle Eastern (MID)
AF:
AC:
960
AN:
5732
European-Non Finnish (NFE)
AF:
AC:
121955
AN:
1110346
Other (OTH)
AF:
AC:
8141
AN:
60186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
7670
15340
23010
30680
38350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4726
9452
14178
18904
23630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.131 AC: 19904AN: 152156Hom.: 1614 Cov.: 32 AF XY: 0.140 AC XY: 10424AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
19904
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
10424
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
3697
AN:
41538
American (AMR)
AF:
AC:
2114
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
367
AN:
3470
East Asian (EAS)
AF:
AC:
1586
AN:
5166
South Asian (SAS)
AF:
AC:
1442
AN:
4806
European-Finnish (FIN)
AF:
AC:
2450
AN:
10564
Middle Eastern (MID)
AF:
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7769
AN:
68016
Other (OTH)
AF:
AC:
255
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
851
1702
2553
3404
4255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
876
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
Sep 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Arrhythmogenic right ventricular dysplasia 13 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.